These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15722241)

  • 41. Control of esophageal and intragastric pH with compounded and manufactured omeprazole in patients with reflux esophagitis: a pilot study.
    Moretzsohn LD; Carvalho EB; Franco JD; Soares MP; Brito EM; Belarmino K; Coelho LG
    Can J Clin Pharmacol; 2009; 16(1):e264-72. PubMed ID: 19383986
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reflux monitoring: role of combined multichannel intraluminal impedance and pH.
    Tutuian R; Castell DO
    Gastrointest Endosc Clin N Am; 2005 Apr; 15(2):361-71. PubMed ID: 15722247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gastroesophageal reflux disease in infants and children.
    Sandritter T
    J Pediatr Health Care; 2003; 17(4):198-205; quiz 204-5. PubMed ID: 12847430
    [No Abstract]   [Full Text] [Related]  

  • 44. Evolving issues in the management of reflux disease?
    Yuan Y; Hunt RH
    Curr Opin Gastroenterol; 2009 Jul; 25(4):342-51. PubMed ID: 19417644
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prolonged pH monitoring: Bravo capsule.
    Pandolfino JE; Kahrilas PJ
    Gastrointest Endosc Clin N Am; 2005 Apr; 15(2):307-18. PubMed ID: 15722243
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lessons learned from intragastric pH monitoring.
    Katz PO
    J Clin Gastroenterol; 2001 Aug; 33(2):107-13. PubMed ID: 11468435
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sustained improvement in symptoms of GERD and antisecretory drug use: 4-year follow-up of the Stretta procedure.
    Noar MD; Lotfi-Emran S
    Gastrointest Endosc; 2007 Mar; 65(3):367-72. PubMed ID: 17321232
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alternative dosing for PPI therapy: rationale and options.
    Johnson DA
    Rev Gastroenterol Disord; 2003; 3 Suppl 4():S10-5. PubMed ID: 14671509
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medical therapy for gastroesophageal reflux disease in 2007.
    Katz PO
    Rev Gastroenterol Disord; 2007; 7(4):193-203. PubMed ID: 18192955
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does simultaneous gastric and esophageal pH monitoring increase the diagnosis of gastroesophageal reflux disease?
    Demir H; Ozen H; Koçak N; Saltik-Temizel IN; Gürakan F
    Turk J Pediatr; 2005; 47(1):14-6. PubMed ID: 15884623
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Review article: immediate-release proton-pump inhibitor therapy--potential advantages.
    Howden CW
    Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():25-30. PubMed ID: 16303034
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Wireless pH monitoring in patients with non-cardiac chest pain.
    Prakash C; Clouse RE
    Am J Gastroenterol; 2006 Mar; 101(3):446-52. PubMed ID: 16542279
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Review article: how valuable are proton-pump inhibitors in establishing a diagnosis of gastro-oesophageal reflux disease?
    Vakil N
    Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():64-9. PubMed ID: 16042661
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reflux monitoring: pH-metry, Bilitec and oesophageal impedance measurements.
    Pohl D; Tutuian R
    Best Pract Res Clin Gastroenterol; 2009; 23(3):299-311. PubMed ID: 19505660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. All PPIs equivalent for treatment of GERD.
    J Fam Pract; 2005 Dec; 54(12):1024. PubMed ID: 16370078
    [No Abstract]   [Full Text] [Related]  

  • 57. Sensitive pepsin immunoassay for detection of laryngopharyngeal reflux.
    Knight J; Lively MO; Johnston N; Dettmar PW; Koufman JA
    Laryngoscope; 2005 Aug; 115(8):1473-8. PubMed ID: 16094128
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-oesophageal reflux for laparoscopic Nissen fundoplication.
    Mainie I; Tutuian R; Agrawal A; Adams D; Castell DO
    Br J Surg; 2006 Dec; 93(12):1483-7. PubMed ID: 17051602
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Value of extended recording time with wireless pH monitoring in evaluating gastroesophageal reflux disease.
    Prakash C; Clouse RE
    Clin Gastroenterol Hepatol; 2005 Apr; 3(4):329-34. PubMed ID: 15822037
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Laryngitis and gastroesophageal reflux disease: increasing prevalence or poor diagnostic tests?
    Vaezi MF
    Am J Gastroenterol; 2004 May; 99(5):786-8. PubMed ID: 15128337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.